View drug registration information details.


ItemsRegistration information
ID299
No299
Brand NameDIABETMIN 850
IngredientsMETFORMIN HYDROCHLORIDE 850 MG
Dosage FormFILM COATED TABLET
Primary PackagingBLISTERPACK
StorageSTORE BELOW 30C, PROTECT FROM LIGHT AND MOISTURE
Shelf Life3 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing CategoryPrescription only
ATC Classification
Pharmaceutical ClassANTIDIABETE
IndicationsTREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS (TYPE 2) IN ADULTS, NOT RESPONDING TO EXCERCISE AND DIETARY MODIFICATION, DIABETMIN MAY BE USED AS MONOTHERAPY OR IN COMBINATION WITH OTHER ORAL ANTIDIABETIC AGENT, OR WITH INSULIN.
ContraindicationsHYPERSENSITIVITY, ANY CONDITION NEEDING CLOSE BLOOD GLUCOSE CONTROL, CONDITION ASSOCIATED WITH HYPOXEMIA, SEVERE, ACUTE, CHRONIC HEPATIC DISEASE, DIAGNOSTIC OR MEDICAL EXAMINATION USING INTRAVASCULAR IODINATED CONTRAST MEDIA
Side EffectsANOREXIA, DIARRHEA, DYSPEPSIA, FLATULENCE, NAUSEA, VOMITING, HEADACHE, MATALLIC TASTE, WEIGHT LOSS, ANEMIA, MEGALOBLASTIC, HYPOGLYCEMIA, LACTIC ACIDOSIS
Unit Price
EDL Yes
DescriptionROUND, WHITE FILM COATED TABLET WITH DEEP CONVEX FACES AND "HOVID" EMBOSSED ON ONE FACE
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerHOVID BHD
CountryMALAYSIA
Import Registration NoMAL05051079AZ
Import Registration Date28/05/2015
ActivityCERTIFICATE RELEASED
Applied Date2023-03-31
FDD Registration No04 I 4911/20
FDD Registration Date2023-06-07
Expiry Date2026-06-06

Back to drug list